Mycobacterium Infections, Nontuberculous clinical trials

The registry lists 54 studies for Mycobacterium Infections, Nontuberculous across more than 10 countries. 19 are recruiting or about to start. 31 of them are mainly about Mycobacterium Infections, Nontuberculous (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 2 narrower conditions too, such as Mycobacterium avium-intracellulare Infection: 160 studies, 35 open.

Get an email when these change. Save the Mycobacterium Infections, Nontuberculous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 24
Recruiting: 12
Terminated: 7
Enrolling by invitation: 5
Status unknown: 4
Not yet recruiting: 2

Phase

Phase 2: 20
Phase 1: 9
Phase 3: 6
Phase 4: 1

Where

United States: 24
Australia: 8
Korea, Republic of: 8
Canada: 6
United Kingdom: 5
Israel: 5

Who runs them

Seoul National University Hospital (4) · Insmed Incorporated (4) · Beijing Chest Hospital (3) · Kevin Winthrop (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Beyond Air Inc. (2) · National Jewish Health (2) · The University of Queensland (2)

What is being tested here

Drugs under test in Mycobacterium Infections, Nontuberculous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Amikacin	3	4	8
Clofazimine	3	1	3
Imipenem	3	1	3
Bedaquiline	2	1	2
Linezolid	2	1	2
Cilastatin	2	0	2
Tigecycline	2	1	2
Cefoxitin	2	1	2
Omadacycline	1	0	2
Sulfamethoxazole	1	0	1

Coming up

1phase 3 study under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Dec 2026Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease · Beijing Chest Hospital
Dec 2026Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria · National Jewish Health
Jan 2027Hypertonic Saline for MAC · Oregon Health and Science University
Mar 2027IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) · Chris Goss
Jul 2027Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection · Alberta Health services
Sep 2027SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID) · Nancy Klimas
Oct 2027Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection · Vancouver Coastal Health

Who these studies take

Of the 12 Mycobacterium Infections, Nontuberculous studies recruiting now, 8 (67%) set no upper age limit and 2 (17%) stop at 75 or younger. 4 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (17%) take healthy volunteers.

Recruiting studies that take each age, of 12
Age	Women	Men
10	4 (33%)	4 (33%)
18	10 (83%)	10 (83%)
30	11 (92%)	11 (92%)
40	11 (92%)	11 (92%)
50	11 (92%)	11 (92%)
65	11 (92%)	11 (92%)
75	10 (83%)	10 (83%)
85	10 (83%)	10 (83%)

Across all 54 studies, recruiting or not: 15% stop at 75 or younger and 11% at 65; 31% take children; 2% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 54. Browse all 54 → or search them.